Elypta Has Granted A US Patent For Its Liquid Biopsy Method For Cancer Metabolism Based Therapeutics Market

 

Cancer Metabolism Based Therapeutics

The advent of advanced therapies and the increasing prevalence of cancer around the globe is facilitating the growth of the global cancer metabolism-based therapeutics market. According to the International Agency for Research on Cancer, cancer is among the leading causes of death worldwide. In 2018, there were 18.1 million new cases and 9.5 million cancer-related deaths worldwide. Targeting cancer metabolism conditions is projected to serve major growth opportunities for rare drugs to treat multiple types of cancer. Changing lifestyle and growing aging population is also contributing to the risk of developing cancer among the population.

Cancer metabolism therapy is based on the idea that tumors have a different metabolic process from normal or healthy cells. While normal cells secrete glycogen and glucose, cancer cells exhibit a lack of glycogen and glucose as well as increased levels of lactic acid. Cancer patients also have a decreased ability to use oxygen as well as an increased use of fatty acids as fuel. This metabolite imbalance is what underlies most of the complications associated with cancer. Cancer therapies that use various types of biological therapies are used to directly target this metabolic disorder.

Regional assessment reveals that, North America is estimated to gain significant growth in the near future and this is attributed to the increasing FDA approval for commercializing cancer metabolism-based therapeutics. For example, in September 2017, the FDA approved Agios’ and Celgene’s enasidenib for acute myeloid leukemia (AML), validating metabolism-modulating drugs as a means of killing cancer cells. Enasidenib (formerly AG-221) is a first-in-class inhibitor of mutated isocitrate dehydro genase 2 (IDH2). Another instance, in August 2020, Tyme Technologies, Inc. a biotechnology company developing cancer metabolism-based therapies (CMBTs™) announced that the U.S. Food and Drug Administration (FDA) has granted the company Orphan Drug Designation for its lead pipeline candidate, SM-88 (racemetyrosine), as a treatment for patients with pancreatic cancer.

Key Developments:

1.      In January 2021, Elypta has granted a US patent for its liquid biopsy method as a cancer metabolism therapy

2.      In January 2019, Drugmaker Lupin announced that it is in the process of developing a pipeline of products under its new drug discovery program to treat various diseases like cancer and metabolic disorders

3.      In December 2020, Rafael Pharmaceuticals Inc. provider of cancer metabolism-based therapeutics announced it has initiated a Phase 2 clinical trial of CPI-613® (devimistat) in combination with hydroxychloroquine in patients with clear cell sarcoma of soft tissue

Comments

Post a Comment

Popular posts from this blog

Bourbon Whiskey Is the Most Popular Whiskey in America and In Many Other Countries around the World

Image
  Whiskey or single malt whiskey is simply a form of distilled beverage made by distilling alcohol from grain mash or even by blending both. Different grains are utilized for different types, such as corn, barley, rye, and wheat. In Scotland, they call their whiskey black tea, a lighter caramel scotch, Irish cream, and liqueur. Whichever form is utilized, the result is usually a flavorful and smooth drink that has a distinct taste, and many people prefer a whiskey with a lower alcohol content. For example, single malt whiskey is the least expensive. The highest price however is the least distilled; that is Bourbon whiskey. Bourbon whiskey is the most popular whiskey in America and in many other countries around the world. Its price range is very wide, starting from as low as about US$ 12 a bottle to over a hundred dollars. So the price definitely varies. Whichever class you belong to, there is always a whiskey that will suit your preference. Single malt scotch whiskey is made ...
Read more

Viral Vectors And Plasmid DNA Manufacturing Market Is Gaining Major Traction With Oxford Biomedica Plc Entering Into A 3-Year Agreement With Boehringer Ingelheim For The Manufacture And Supply Of Various Types Of Viral Vectors

Image
  Viral Vectors are proteins that have been discovered to be essential for the spread of various viruses and infectious agents. These proteins can cause serious health risks if they are improperly introduced or if a wrong agent is used to fight them off. Viral vectors have often been used in various gene therapy procedures with the ultimate objective of curing various ailments in the biological fields of neurology, gene therapy, cancer, and metabolic disorder. Clinical studies regarding viral vectors remain one of the key factors in the manufacturing of viral vectors. Plasmids are used to deliver DNA contain genes for antibiotic resistance. In fact, scientists have developed many uses of plasmids and created software to record the DNA sequences of plasmids for applications in various techniques. Thus, such continuous R&D activities can potentially stimulate growth of the viral vectors and plasmid DNA manufacturing market . Recently, in April 2021, Oxford Biomedica plc entered...
Read more

Hard Surface Flooring Market Is Expected To Witness Robust Growth As Mohawk Industries Introduces Newly Imagined 30,000-Square Foot Floor Space At The International Surface Event (TISE)

Image
  There are many reasons why people choose hard surface floors over other types of flooring. Hard surfaces offer a level of durability and are very aesthetically pleasing. Unfortunately, choosing this type of flooring can be confusing and costly. There are four main hard surface varieties namely vinyl plank, laminate, solid hardwood, and engineered wood. Each has their own style strengths and provide different advantages. Increasing population coupled with rapid urbanization is expected to drive growth of the global hard surface flooring market . According to the United Nations (UN), by 2050, around 68% of the global population is expected to live in urban areas, increasing from 55% in 2018. According to the same source, in 2018, around 4.2 billion people were living in urban areas, increasing from 751 million in 1950. Furthermore, according to the World Bank, in 2019, the global population reached 7.674 billion, increasing from 6.84 billion in 2009. As a result of this, building...
Read more